Second, while the majority of patient tumor cells (>95%) were strongly positive (+++) for GFAP, a marker of mature/differentiated glial cells, there was a steady decrease of GFAP+ cells in PDOX tumors (26-50%). This evidence concerns the gene GFAP and neoplasm.